The AI-Enabled Ultrasound Diagnostics Market is projected to register a strong CAGR during the forecast period (2026-2031).
The AI-Enabled Ultrasound Diagnostics Market is growing as artificial intelligence enhances imaging accuracy, speed, and workflow efficiency. AI integration supports real-time analysis, automated measurements, and early disease detection across cardiology, obstetrics, and radiology. Increasing adoption in hospitals, diagnostic centers, and point-of-care settings is driving global market growth.
Ultrasound diagnosis using AI is a technology that brings together conventional ultrasound imaging with artificial intelligence. This combination helps physicians interpret ultrasound images more accurately, reduces the need for physician involvement in ultrasound examinations, and enhances the speed at which a diagnosis can be made based on information gathered during an ultrasound exam. The growing need for improved early detection of disease, the development of automated measurement tools for ultrasound, and the ability of physicians to make clinical decisions more quickly have contributed to significant market growth projected through 2025. AI technology is currently being utilised to identify abnormal findings in ultrasound images indicating cardiovascular pathology, obstetrical pathologies, orthopaedic/musculoskeletal pathologies and other types of medical conditions at a much higher level of reliability and accuracy compared with traditional ultrasound diagnostics. Improved integration of AI technology with cloud computing and advanced software analytics has enabled remote diagnosis of patients and has increased the utilisation of telemedicine. In addition, the increased availability of investment for the establishment of smart healthcare innovation infrastructure, as well as the increase in understanding of the clinical advantages of AI technology and applications, will contribute to the increasing adoption of AI technology at a global level.
Rising Demand for Automated and Accurate Diagnostics: As healthcare providers seek ways to minimize their dependence on operators and reduce human error, they are increasingly turning to AI-enabled ultrasound systems. Automation allows for accurate measurements and consistent interpretation of images, giving providers greater confidence when diagnosing patients. Facilities--including hospitals and clinics--are turning to these solutions to improve their patients' health outcomes, especially in cardiac care, obstetrics, and radiology, where accuracy is paramount.
Increasing Adoption of Portable and Point-of-Care Devices: Portable, handheld AI-integrated ultrasound devices allow providers to make quick, bedside diagnoses--particularly in emergency situations or remote areas. The use of point-of-care devices is becoming more widespread in rural areas and smaller clinics, allowing for real-time imaging and analysis of the patient. The greater flexibility associated with point-of-care devices creates faster decision-making processes, improves patient management, and contributes to the growth of the global ultrasound market.
Technological Advancements in AI Algorithms: The continuous advancement of deep learning and machine learning algorithms has resulted in improved clarity of ultrasound images, increased accuracy of the detection of abnormalities, and enhanced workflow efficiency. State-of-the-art software performs automated calculations, recognizes patterns, and conducts predictive analysis of ultrasound images. Through these advancements, clinicians will be able to identify subtle pathologies at an earlier stage, providing them with greater confidence to integrate ultrasound findings into their hospital information technology systems, and thus, accelerating the adoption of ultrasound on a more global level.
Growing Prevalence of Chronic Diseases: The increasing occurrence of chronic conditions, including cardiovascular disease, complications associated with obstetrics, and other chronic diseases, has resulted in the need for more frequent monitoring of patients. Ultrasound technology using AI enables the earlier diagnosis, tracking, and planning of treatment for chronic diseases. Therefore, healthcare systems will continue to invest in these technologies to reduce hospital visits; decrease the cost of care, and improve the patient's health outcome, thus contributing to an increase in the overall demand for ultrasound technology on a global basis.
The High initial costs, regulatory hurdles, and the need for trained personnel limit adoption in some regions. Opportunities lie in developing cost-effective, AI-enabled portable systems, cloud-based diagnostics, and expanding applications in cardiology, obstetrics, and musculoskeletal imaging. Increasing telemedicine adoption and integration with hospital IT systems further support market growth.
March 2025: Canon Medical Systems received U.S.?FDA clearance for its Aplio i?series diagnostic ultrasound systems with upgraded AI?powered imaging software. The new software version leverages deep learning to enhance image clarity and spatial resolution while reducing artefacts, significantly improving diagnostic confidence and workflow efficiency in clinical ultrasound imaging. This represents a notable step in AI integration for ultrasound diagnostics.
The market is segmented by product type, technology, application and geography.
AI software solutions play a vital role in revolutionising how images are interpreted, measurements are automated, and workflows are optimised. These software programs can be integrated with existing ultrasound systems to provide increased accuracy and efficiency in diagnostics. Advancements have been made in features such as anomaly detection and predictive analysis, as well as cloud-based reporting, allowing hospitals and clinics to improve their patient-care capabilities and reduce the need for operator input on test results. The need for precision diagnostics across all imaging domains (cardiology, obstetrics, etc.) enables these AI software solutions to be adopted at an increasing rate.
AI-powered image analysis revolutionises the way ultrasound scans can be interpreted automatically, therefore reducing human error and increasing consistency in diagnostic results. The ability to detect minute anomalies in real-time provides a means of supporting early diagnosis of disease processes and assists clinicians in making decisions regarding complex cases. AI-assisted image analysis will utilise deep learning and cloud-based analytics, allowing for faster processing speeds, greater opportunity for predictive analysis and remote diagnostics, and making AI image analysis a critical component of modern ultrasound workflows.
AI-enabled ultrasound in cardiology will provide improved accuracy and precision in assessing the structure and function of the heart, its valves, and the pattern of blood flow through those structures. By utilising automated measurements and detecting anomalies automatically, the variability between operators will be reduced, and the ability to diagnose cardiovascular conditions earlier will be enhanced. By 2025, hospitals will continue to be increasingly interested in the use of AI-assisted cardiac ultrasound to improve workflow efficiency, enhance patient outcomes, and create opportunities for predictive analytics in treatment decisions.
The North America Region is Leading in AI-Enabled Ultrasound Diagnostics Due to Its Advanced Infrastructure and High Rate of AI adoption, as well as Major Players in the Industry. The Healthcare Sector has the Highest Rate of Use of AI-Enabled Ultrasound Systems (Cardiology, Obstetrics, Radiology). In Addition, Government Programs are Supporting the Integration of AI Into Healthcare and Ongoing Investments in Research and Development Supporting the Growth of AI-Enabled Ultrasound Adoption and Innovation.
Moderate growth in the AI-enabled ultrasound system market in South America is due to the continuing development of healthcare infrastructure improvements and the increase in awareness of AI diagnostics in the general population. Increased adoption of AI-enabled systems will be driven by healthcare providers and diagnostic imaging facilities seeking to improve their workflow and early disease detection. There are limitations to the resources and economic factors that will limit the use of AI-enabled ultrasound in large numbers; however, any improvements to healthcare access and targeted investments will result in continued steady growth across the region.
The europe region is experiencing continued growth with a focus on integrating ai within clinical imaging. Hospitals, diagnostic imaging centres, and educational research university have all increased their adoption of ai-enabled systems for their daily operations, supporting improved diagnostic results and reducing workflow delays. The increased availability of regulations and supporting investments related to the digitalisation of the healthcare systems has further increased the penetration of the regional market. The increasing number of individuals with chronic illnesses and the need for early diagnosis will further influence the demand for these systems throughout Europe.
MEA is emerging in the AI-enabled ultrasound market, supported by increasing healthcare investments and digital health initiatives. Hospitals in the Middle East are adopting AI-assisted imaging for cardiology and obstetrics, while Africa sees gradual adoption driven by international aid programs. Rising awareness of early disease diagnosis and improving infrastructure are expected to drive steady growth across the region.
The Asia-Pacific region is the fastest-growing region for AI-enabled ultrasound technologies due to the increasing number of healthcare facilities and the growing number of individuals who have been diagnosed with chronic diseases and lack knowledge of how AI will benefit their clinical outcomes. Countries such as China, India, and Japan are actively investing in the infrastructure needed to implement AI-enabled ultrasound devices into their facilities for use in hospitals and outpatient facilities. In addition, the increased demand for more portable devices and point-of-care devices will accelerate growth in the region. The numerous government and private sector initiatives in the market will aid in facilitating the growth of AI-enabled ultrasound throughout many of the urban and rural areas.
GE HealthCare
Siemens Healthineers
Philips Healthcare
Canon Medical Systems
Fujifilm Healthcare
Samsung Medison
Mindray Medical
Butterfly Network
Qure AI
Caption Health
GE Healthcare currently leads the industry for artificial-intelligence-enabled ultrasound through innovative systems and software that feature integrated machine learning algorithms to improve image quality and provide automated measurements. GE Healthcare offers a variety of solutions to improve clinical workflow with respect to performing diagnostic imaging across cardiology, obstetrics/gynaecology, and general imaging and therefore improve the diagnostic accuracy and operational efficiency of hospitals and diagnostic imaging centres.
Butterfly Network’s device is an example of the next generation of handheld ultrasound technologies that use artificial intelligence (AI) to enable users to perform Ultrasound imaging with their smartphones and tablets. Butterfly Network’s advanced algorithms for AI provide technical assistance in both image acquisition and image interpretation, enabling healthcare providers to offer Ultrasound exams at the point of care. This is particularly important for the delivery of care in remote areas, in emergency rooms, and in primary care clinics when traditional diagnostic imaging is unavailable.
| Report Metric | Details |
|---|---|
| Forecast Unit | Billion |
| Growth Rate | Ask for a sample |
| Study Period | 2021 to 2031 |
| Historical Data | 2021 to 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 – 2031 |
| Segmentation | Product Type, Technology, Application, Geography |
| Geographical Segmentation | North America, South America, Europe, Middle East and Africa, Asia Pacific |
| Companies |
|